Changes of cerebrovascular CO2 reactivity during normal aging

Stroke

Volumn 29, Issue 7, 1998, Pages 1311-1314

  Kastrup, Andreas ^b   Dichgans, Johannes ^b   Niemeier, Matthias ^b   Schabet, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

Carbon dioxide; Cerebral blood flow velocity; Doppler; Transcranial; Ultrasonography

Indexed keywords

CARBON DIOXIDE;

ADULT; AGED; AGING; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; CHEMOSENSITIVITY; DOPPLER FLOWMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MALE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; STRESS; BRAIN CIRCULATION; COMPARATIVE STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; ESTROGEN THERAPY; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; SEXUAL DEVELOPMENT;

ADULT; AGED; AGING; BLOOD FLOW VELOCITY; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREMENOPAUSE; REFERENCE VALUES; SEX CHARACTERISTICS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0031596067     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.7.1311     Document Type: Article

References (30)

1. 2 reactivity in stroke-age normal controls. Neurology. 1983; 33:391-399.
2. Reich T, Rusinek H. Cerebral cortical and white matter reactivity to carbon dioxide. Stroke. 1989;20:453-457.
3. Adams RJ, Nichols FT, Hess DC. Normal values and physiologic variables. In: Newell DW, Aaslid R, eds, Transcranial Doppler. New York, NY: Raven Press; 1992:41-47.
4. Tsuda Y, Hartmann A. Changes in hyperfrontality of cerebral blood flow and carbon dioxide reactivity with age. Stroke. 1989;20:1667-1673.
5. Yamaguchi F, Meyer JS, Sakai F, Yamamoto M. Normal human aging and cerebral vasoconstrictive responses to hypocapnia. J Neurol Sci. 1979;44:87-94.
6. Yamamoto M, Meyer JS, Sakai F, Yamaguchi F. Aging and cerebral vasodilator responses to hypercarhia. Arch Neurol. 1980;37:489-496.
7. Gotoh F, Meyer JS, Takagi Y. Cerebral effects of hyperventilation in man. Arch Neurol. 1965;12:410-423.
8. 2. Am J Med. 1953; 15:171-174.
9. Hachinski VC, Iliff LD, Zilhka E, Boulay GH, McAllister VL, Marshall J, Russell RWR, Symon L. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632-637.
10. Lassen NA, Munck O, Tottey ER. Mental function and cerebral oxygen consumption in organic dementia. Arch Neurol Psychiatr. 1957;77: 126-133.
11. 2 reactivity in normal individuals. Stroke. 1997;12: 2353-2356.
12. 2 reactivity in interictal migraineurs: a transcranial Doppler study. Headache. In press.
13. Huber P, Handa J. Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of cerebral arteries. Invest Radiol. 1967;2:17-32.
14. 2 tensions. Neuroradiology. 1976;10:257-262.
15. Poulin MJ, Robbins PA. Indexes of flow and cross-sectional area of the middle cerebral artery using Doppler ultrasound during hypoxia and hypercapnia in humans. Stroke. 1996;27:2244-2250.
16. Bishop CCR, Powell S, Rutt D, Browse NL. Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study. Stroke. 1986;17:913-915.
17. 2 in newborn pig brain microvascular endothelial cells. Am J Physiol. 1993;264:H1485-1492.
18. Leffler CW, Mirro R, Pharris LJ, Shibata M. Permissive role of prostacyclin in cerebral vasodilation to hypercapnia in newborn pigs. Am J Physiol. 1994;267:H285-291.
19. 2 and cerebral circulation in newborn pigs: cyclic nucleotides and prostanoids in vascular regulation. Am J Physiol. 1994;266:H1494-1501.
20. 2 response in cerebral arteries of the newborn pig: role of phospholipase, cyclooxygenase, and lipooxygenase pathways. Circ Res. 1988;62:1019-11026.
21. 2 by cerebral arteries. Stroke. 1979;10:306-309.
22. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Engl J Med. 1979;300: 1142-1147.
23. Bolego C, Cignarella A, Ruzza R, Zaarour C, Messi E, Zanisi M, Puglisis L. Differential effects of low-and high-dose estrogen treatments on vascular responses in female rats. Life Sci. 1997;60:2291-2302.
24. Chang WC, Nakao J, Orimo H, Murota SI. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochem Biophys Acta. 1980;620:472-482.
25. Fogelberg M, Vesterqvist O, Diczflalusy U, Henriksson P. Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation. Eur J Clin Invest. 1990;20:105-110.
26. Masotti G, Poggesi L, Galanti G, Trotta F, Serni GGN. Prostacyclin production in man. In: Lewis PJ, O'Grady J, eds. Clinical Pharmacology of Prostacyclin. New York, NY: Raven; 1981:9-20.
27. Mikkola T, Ranta V, Orpana A, Viinikka L, Ylikorkala O. Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells. Fertil Steril. 1996;66:389-393.
28. Petitti DB, Sidney S, Quesenberry CP, Bernstein A. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke. 1998;29:23-28.
29. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Arch Intern Med. 1993;153:73-79.
30. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.